Market Summary
USD252.04+2.24
Market Closed0.90%
DHR Stock Price
DHR RSI Chart
DHR Valuation
DHR Price/Sales (Trailing)
DHR Profitability
DHR Fundamentals
DHR Revenue
DHR Earnings
Price Action
52 Week Range
233.47303.82
(Low)(High)
Last 7 days
1.4%
Last 30 days
0.9%
Last 90 days
-5.9%
Trailing 12 Months
-15.9%
DHR Financial Health
DHR Investor Care
Peers (Alternatives to Danaher)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
DHR | 181.9B | 31.5B | 0.92% | -15.91% | 25.24 | 5.78 | 6.85% | 12.06% |
SYK | 106.2B | 18.4B | 6.78% | 4.67% | 45.05 | 5.76 | 7.84% | 18.25% |
MDT | 105.3B | 30.8B | -4.37% | -28.48% | 25.91 | 3.42 | -3.19% | -17.38% |
ISRG | 88.0B | 6.2B | 9.55% | -17.45% | 66.52 | 14.14 | 8.97% | -22.43% |
EW | 49.6B | 5.4B | 1.40% | -30.34% | 32.6 | 9.22 | 2.86% | 1.25% |
| MID-CAP | ||||||||
PEN | 10.6B | 847.1M | 6.58% | 27.77% | -5.3K | 12.46 | 13.32% | -137.89% |
GMED | 5.6B | 1.0B | -4.49% | -25.70% | 32.22 | 5.43 | 6.76% | 24.45% |
IART | 4.7B | 1.6B | 1.62% | -13.99% | 26 | 3.01 | 0.99% | 6.79% |
STAA | 3.0B | 284.4M | 12.67% | -24.43% | 77.64 | 10.58 | 23.40% | 58.18% |
| SMALL-CAP | ||||||||
MLAB | 911.6M | 222.4M | -3.27% | -32.68% | -622.28 | 4.1 | 36.07% | -119.34% |
AXDX | 69.0M | 13.1M | 39.22% | -49.29% | -0.98 | 5.26 | 13.64% | 4.49% |
KEQU | 42.9M | 195.0M | -0.59% | 6.54% | -16.06 | 0.22 | 29.53% | 63.61% |
AEMD | 8.7M | 3.5M | -22.21% | -74.59% | -0.65 | 2.45 | 44.21% | -50.10% |
THMO | 1.8M | 10.2M | -20.81% | 288.54% | -0.16 | 0.17 | 15.89% | 6.85% |
Financials for Danaher
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Revenue | 0.7% | 31,471 | 31,250 | 30,816 | 30,283 | 29,453 |
| Gross Profit | 0.0% | 18,949 | 18,953 | 18,728 | 18,404 | 17,952 |
| S&GA Expenses | -1.2% | 8,516 | 8,620 | 8,533 | 8,414 | 8,198 |
| R&D Expenses | -2.4% | 1,745 | 1,787 | 1,808 | 1,803 | 1,742 |
| EBITDA | 1.4% | 9,241 | 9,117 | 8,603 | 8,587 | - |
| EBITDA Margin | 0.6% | 0.29* | 0.29* | 1.61* | 0.28* | - |
| Earnings Before Taxes | 1.3% | 8,292 | 8,184 | 7,640 | 7,614 | 7,598 |
| EBT Margin | 0.6% | 0.26* | 0.26* | 1.43* | 0.25* | - |
| Interest Expenses | 3.9% | 211 | 203 | 223 | 234 | 238 |
| Net Income | 6.6% | 7,209 | 6,765 | 6,351 | 6,456 | 6,433 |
| Net Income Margin | 5.8% | 0.23* | 0.22* | 1.19* | 0.21* | - |
| Free Cahsflow | 4.2% | 7,367 | 7,068 | 7,051 | 7,162 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | 4.1% | 84,350 | 81,030 | 81,806 | 83,392 | 83,184 |
| Current Assets | 11.5% | 15,883 | 14,250 | 13,229 | 12,670 | 11,648 |
| Cash Equivalents | 16.4% | 5,995 | 5,150 | 3,984 | 3,717 | 2,586 |
| Inventory | -3.9% | 3,110 | 3,236 | 3,257 | 3,072 | 2,767 |
| Net PPE | 6.4% | 3,956 | 3,719 | 3,794 | 3,815 | 3,790 |
| Goodwill | 3.9% | 39,752 | 38,251 | 39,276 | 40,663 | 41,184 |
| Current Liabilities | 4.8% | 8,389 | 8,002 | 7,556 | 7,547 | 8,140 |
| LT Debt, Non Current | 2.9% | 19,086 | 18,542 | 20,052 | 21,768 | 22,168 |
| Shareholder's Equity | 6.6% | 50,082 | 46,985 | 46,594 | 46,356 | 45,167 |
| Retained Earnings | 5.5% | 39,205 | 37,177 | 35,808 | 34,332 | 32,827 |
| Additional Paid-In Capital | 0.7% | 12,072 | 11,985 | 11,854 | 10,123 | 10,090 |
| Accumulated Depreciation | 2.5% | 3,627 | 3,538 | 3,517 | 3,465 | - |
| Shares Outstanding | 0.1% | 728 | 728 | 727 | 716 | 715 |
| Minority Interest | 0% | 8.00 | 8.00 | 7.00 | 6.00 | 10.00 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Cashflow From Operations | 2.5% | 8,519 | 8,311 | 8,335 | 8,455 | 8,358 |
| Share Based Compensation | 2.1% | 336 | 329 | 292 | 244 | 218 |
| Cashflow From Investing | 2.7% | -2,234 | -2,297 | -11,830 | -12,497 | -12,987 |
| Cashflow From Financing | 16.7% | -2,570 | -3,086 | 449 | 1,470 | 1,295 |
| Dividend Payments | 1.5% | 818 | 806 | 793 | 764 | 742 |
Risks for DHR
What is the probability of a big loss on DHR?
40%
Probability that Danaher stock will be more than 20% underwater in next one year
0%
Probability that Danaher stock will be more than 30% underwater in next one year.
0%
Probability that Danaher stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does DHR drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Danaher was unfortunately bought at previous high price.
Drawdowns
Returns for DHR
Cumulative Returns on DHR
18.8%
10-Year Cumulative Returns
20%
7-Year Cumulative Returns
21.1%
5-Year Cumulative Returns
21.4%
3-Year Cumulative Returns
What are the long-term rolling returns for DHR?
FIve years rolling returns for Danaher.
Annualized Returns
Which funds bought or sold DHR recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-28 | Werba Rubin Papier Wealth Management | new | - | 331,288 | 331,288 | 0.14% |
2023-03-24 | PALISADE CAPITAL MANAGEMENT, LP | reduced | -10.41 | -1,665,740 | 15,425,300 | 0.41% |
2023-03-24 | PALISADE CAPITAL MANAGEMENT, LP | reduced | -0.76 | 951,246 | 49,043,200 | 1.32% |
2023-03-23 | ETF MANAGERS GROUP, LLC | added | 3.85 | 40,174 | 644,174 | 0.03% |
2023-03-23 | MetLife Investment Management, LLC | reduced | -1.57 | 517,983 | 45,839,100 | 0.37% |
2023-03-22 | Pictet North America Advisors SA | added | 867 | 1,791,810 | 1,992,240 | 0.34% |
2023-03-17 | American Portfolios Advisors | unchanged | - | 1,456 | 80,849 | -% |
2023-03-17 | American Portfolios Advisors | reduced | -1.24 | 20,552 | 3,340,810 | 0.14% |
2023-03-15 | B. Riley Wealth Advisors, Inc. | added | 2.71 | 140,066 | 2,651,070 | 0.07% |
2023-03-10 | MATHER GROUP, LLC. | added | 21.53 | 224,379 | 1,126,380 | 0.02% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Danaher News
Schedule 13G FIlings of Danaher
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 09, 2023 | vanguard group inc | 7.48% | 54,428,553 | SC 13G/A | |
| Jan 31, 2023 | blackrock inc. | 7.1% | 51,630,040 | SC 13G/A | |
| Mar 11, 2022 | blackrock inc. | 6.4% | 45,990,561 | SC 13G/A | |
| Feb 09, 2022 | vanguard group inc | 6.99% | 49,960,190 | SC 13G/A | |
| Feb 08, 2022 | blackrock inc. | 6.4% | 45,990,561 | SC 13G | |
| Nov 02, 2021 | rales mitchell p | 4.99% | 35,669,704 | SC 13D/A | |
| Jun 14, 2021 | rales steven m | 6.1% | 43,454,958 | SC 13D/A | |
| Jun 14, 2021 | rales mitchell p | 5.0% | 35,669,704 | SC 13D/A | |
| Feb 16, 2021 | price t rowe associates inc /md/ | 4.4% | 31,588,419 | SC 13G/A | |
| Feb 10, 2021 | vanguard group inc | 6.86% | 48,739,681 | SC 13G/A |
DHR Fair Value
Danaher fair value in different scenarios
The table shows the Fair Value estimates for Danaher for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
| Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
|---|---|---|---|---|---|
| Very Low Inflation | 109.40 -56.59% | 140.25 -44.35% | 260.92 3.52% | 464.42 84.26% | 618.07 145.23% |
| Current Inflation | 100.57 -60.10% | 127.10 -49.57% | 229.20 -9.06% | 399.89 58.66% | 528.46 109.67% |
| Very High Inflation | 89.63 -64.44% | 111.14 -55.90% | 192.11 -23.78% | 326.01 29.35% | 426.53 69.23% |
Historical Danaher Fair Value Estimates
Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price
Recent SEC filings of Danaher
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 29, 2023 | ARS | ARS | |
| Mar 29, 2023 | DEF 14A | DEF 14A | |
| Mar 29, 2023 | DEFA14A | DEFA14A | |
| Feb 28, 2023 | 4 | Insider Trading | |
| Feb 28, 2023 | 4 | Insider Trading | |
| Feb 28, 2023 | 4 | Insider Trading | |
| Feb 28, 2023 | 4 | Insider Trading | |
| Feb 28, 2023 | 4 | Insider Trading | |
| Feb 28, 2023 | 4 | Insider Trading | |
| Feb 28, 2023 | 4 | Insider Trading |
Latest Insider Trading transactions for DHR
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-02-24 | Honeycutt Jennifer | sold (taxes) | -119,328 | 249 | -479 | executive vice president |
2023-02-24 | Gutierrez-Ramos Jose-Carlos | sold (taxes) | -119,827 | 249 | -481 | svp, chief science officer |
2023-02-24 | Bouda Christopher | acquired | - | - | 1,004 | vp, chief accounting officer |
2023-02-24 | Couchara Georgeann | sold (taxes) | -81,711 | 249 | -328 | svp, human resources |
2023-02-24 | Weidemanis Joakim | sold (taxes) | -365,459 | 249 | -1,467 | executive vice president |
2023-02-24 | Blair Rainer | sold (taxes) | -505,215 | 249 | -2,028 | president & ceo |
2023-02-24 | McGrew Matthew | sold (taxes) | -155,700 | 249 | -625 | evp & chief financial officer |
2023-02-24 | Raskas Daniel | sold (taxes) | -127,051 | 249 | -510 | svp - corporate development |
2023-02-24 | King William | sold (taxes) | -118,332 | 249 | -475 | svp, strategic development |
2023-02-24 | Bouda Christopher | sold (taxes) | -69,504 | 249 | -279 | vp, chief accounting officer |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
DHR Income Statement
2022-12-31Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions | 12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | ||||
| Income Statement [Abstract] | ||||||
| Sales | $ 31,471 | $ 29,453 | $ 22,284 | |||
| Cost of sales | (12,522) | (11,501) | (9,809) | |||
| Gross profit | 18,949 | 17,952 | 12,475 | |||
| Operating costs: | ||||||
| Selling, general and administrative expenses | (8,516) | (8,198) | (6,896) | |||
| Research and development expenses | (1,745) | (1,742) | (1,348) | |||
| Other operating expenses | 0 | (547) | 0 | |||
| Operating profit | 8,688 | 7,465 | 4,231 | |||
| Nonoperating income (expense): | ||||||
| Other income (expense), net | (226) | 456 | 494 | |||
| Loss on early extinguishment of borrowings | 0 | (96) | (26) | |||
| Interest expense | (211) | (238) | (275) | |||
| Interest income | 41 | 11 | 71 | |||
| Earnings from continuing operations before income taxes | 8,292 | 7,598 | 4,495 | |||
| Income taxes | (1,083) | (1,251) | (849) | |||
| Net earnings from continuing operations | 7,209 | 6,347 | 3,646 | |||
| Earnings from discontinued operations, net of income taxes | 0 | 86 | 0 | |||
| Net earnings | 7,209 | 6,433 | 3,646 | |||
| Mandatory convertible preferred stock dividends | (106) | (164) | (136) | |||
| Net earnings attributable to common stockholders | $ 7,103 | $ 6,269 | $ 3,510 | |||
| Net earnings per common share: | ||||||
| Net earnings per common share from continuing operations, basic | $ 9.80 | $ 8.65 | $ 4.97 | |||
| Net earnings per common share from continuing operations, diluted | 9.66 | 8.50 | 4.89 | |||
| Net earnings per common share from discontinued operations, basic | 0 | 0.12 | 0 | |||
| Net earnings per common share from discontinued operations, diluted | 0 | 0.12 | 0 | |||
| Net earnings per common share, basic | 9.80 | 8.77 | 4.97 | |||
| Net earnings per common share, diluted | $ 9.66 | $ 8.61 | [1] | $ 4.89 | ||
| Average common stock and common equivalent shares outstanding: | ||||||
| Basic | 725.1 | 714.6 | 706.2 | |||
| Diluted | 737.1 | 736.8 | 718.7 | |||
| ||||||
DHR Balance Sheet
2022-12-31Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
|---|---|---|
| Current assets: | ||
| Cash and equivalents | $ 5,995 | $ 2,586 |
| Trade accounts receivable, less allowance for doubtful accounts of $126 as of December 31, 2022 and $124 as of December 31, 2021 | 4,918 | 4,631 |
| Inventories | 3,110 | 2,767 |
| Prepaid expenses and other current assets | 1,860 | 1,664 |
| Total current assets | 15,883 | 11,648 |
| Property, plant and equipment, net | 3,956 | 3,790 |
| Other long-term assets | 4,459 | 3,719 |
| Goodwill | 39,752 | 41,184 |
| Other intangible assets, net | 20,300 | 22,843 |
| Total assets | 84,350 | 83,184 |
| Current liabilities: | ||
| Notes payable and current portion of long-term debt | 591 | 8 |
| Trade accounts payable | 2,296 | 2,569 |
| Accrued expenses and other liabilities | 5,502 | 5,563 |
| Total current liabilities | 8,389 | 8,140 |
| Other long-term liabilities | 6,785 | 7,699 |
| Long-term debt | 19,086 | 22,168 |
| Stockholders’ equity: | ||
| Preferred stock, no par value, 15.0 million shares authorized; no shares and 1.65 million shares of 4.75% Mandatory Convertible Preferred Stock, Series A, issued and outstanding as of December 31, 2022 and December 31, 2021, respectively; 1.72 million shares of 5.00% Mandatory Convertible Preferred Stock, Series B, issued and outstanding as of December 31, 2022 and December 31, 2021 | 1,668 | 3,268 |
| Common stock - $0.01 par value, 2.0 billion shares authorized; 869.3 million issued and 728.3 million outstanding as of December 31, 2022; 855.7 million issued and 715.0 million outstanding as of December 31, 2021 | 9 | 9 |
| Additional paid-in capital | 12,072 | 10,090 |
| Retained earnings | 39,205 | 32,827 |
| Accumulated other comprehensive income (loss) | (2,872) | (1,027) |
| Total Danaher stockholders’ equity | 50,082 | 45,167 |
| Noncontrolling interests | 8 | 10 |
| Total stockholders’ equity | 50,090 | 45,177 |
| Total liabilities and stockholders’ equity | $ 84,350 | $ 83,184 |